World Heart shuffles top two executives

Article Abstract:

Ottawa, Ont.-based World Heart Corp. has announced several top management changes as it prepares to implant its artificial heart product in a patient. World Heart, which developed the Heartsaver medical device, has appointed Tofy Mussivand as its new chairman and chief scientific officer.

Executive changes & profiles, Officials and employees, Appointments, resignations and dismissals, World Heart Corp., WHRT

---

Transition therapeutics confident of deal with Novo on diabetes treatment

Article Abstract:

Transition Therapeutics Inc. is on the verge of a breakthrough treatment for diabetes that is close to a cure. Nova Nordisk AS of Denmark will conclude a year long evaluation to license Transition's islet neogenesis therapy (INT) designed to stimulate the body to regenerate insulin-producing islet cells in the pancreas for $51.5 million over a period of 2005 to 2007 or 2008.

Product development, Transition Therapeutics Inc.

---

Boston offers to buy Guidant

Article Abstract:

The details on Boston Scientific Corp.'s acquisition of Guidant Corp., for $25 billion, are presented.

United States, Acquisitions & mergers, Mergers, acquisitions and divestments, Company acquisition/merger, Boston Scientific Corp., Guidant Corp., GDT

Similar abstracts:

• Abstracts: Interpublic's changing of the guard replaces a senior statesman of advertising with a veteran. Cliff Freeman's campaign for Church's uses the working class and humor to sell chicken
• Abstracts: MCI: Accusations of fraud further tangle future of long-distance giant. AT&T's residential rates to rise
• Abstracts: Manulife may need to put cash into venture with troubled partner. Indonesia warned in Manulife case
• Abstracts: PM vows to 'fight fire with fire' in trade dispute with Brazil. Trade War Looms With Brazil
• Abstracts: Banks asked to broaden search for customer links to bin Laden. National Bank wins battle for site

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.